Seon-Wook Hwang
Chief Executive Officer at NOVMETAPHARMA CO., LTD.
Net worth: 17 M $ as of 30/07/2023
Profile
Seon-Wook Hwang is currently the President, Co-Chief Executive Officer & Director at NovMetaPharma Co., Ltd.
He is also the Chief Executive Officer at PNC Holdings Co. Ltd.
and NovMetaHealth Co. Ltd.
Mr. Hwang completed his undergraduate and graduate degrees at Chung-Ang University.
Known holdings in public companies
Company | Date | Number of shares | Valuation | Valuation date |
---|---|---|---|---|
NOVMETAPHARMA CO., LTD.
9.36% | 29/06/2023 | 1,038,030 ( 9.36% ) | 17 M $ | 30/07/2023 |
Seon-Wook Hwang active positions
Companies | Position | Start |
---|---|---|
NOVMETAPHARMA CO., LTD. | Chief Executive Officer | 03/11/2010 |
NovMetaHealth Co. Ltd.
NovMetaHealth Co. Ltd. Pharmaceuticals: MajorHealth Technology Part of NovMetaPharma Co., Ltd., NovMetaHealth Co. Ltd. develops and manufactures products related to metabolic diseases. The company is based in Seoul, South Korea. The South Korean company was founded in 2016. Seon-Wook Hwang has been the CEO of the company since 2016. NovMetaHealth Co. was acquired by NovMetaPharma Co., Ltd. on March 10, 2022 for $12.61 million. | Chief Executive Officer | 29/02/2016 |
PNC Holdings Co. Ltd. | Chief Executive Officer | 31/08/2015 |
Training of Seon-Wook Hwang
Chung-Ang University | Graduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 1 |
---|---|
NOVMETAPHARMA CO., LTD. | Health Technology |
Private companies | 2 |
---|---|
PNC Holdings Co. Ltd. | |
NovMetaHealth Co. Ltd.
NovMetaHealth Co. Ltd. Pharmaceuticals: MajorHealth Technology Part of NovMetaPharma Co., Ltd., NovMetaHealth Co. Ltd. develops and manufactures products related to metabolic diseases. The company is based in Seoul, South Korea. The South Korean company was founded in 2016. Seon-Wook Hwang has been the CEO of the company since 2016. NovMetaHealth Co. was acquired by NovMetaPharma Co., Ltd. on March 10, 2022 for $12.61 million. | Health Technology |
- Stock Market
- Insiders
- Seon-Wook Hwang